ABVX
Abivax S.A. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang +30.0% ·
aliran saham +30.0% ·
posisi baru bersih +20.0%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | +12 | 15.45M | $2.06B | +16 | −3 |
| Q1 2026 | 72 | -1 | 18.00M | $2.00B | +4 | −5 |
| Q4 2025 | 72 | +3 | 22.08M | $2.98B | +3 | — |
| Q3 2025 | 11 | +5 | 9.45M | $802.20M | +5 | — |
| Q2 2025 | 4 | -1 | 2.69M | $20.57M | — | −1 |
| Q1 2025 | 5 | 0 | 2.48M | $15.51M | +1 | −1 |
| Q4 2024 | 5 | -1 | 1.91M | $14.02M | +1 | −2 |
| Q3 2024 | 6 | +1 | 2.23M | $25.72M | +1 | — |
| Q2 2024 | 5 | — | 1.50M | $19.77M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 2.93M | +1642.5% | $248.36M | 0.6% | ▲ Add | 6 | SEC ↗ |
| 2 | Morgan Stanley ✦ | 1.47M | — | $124.86M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 1.47M | — | $124.86M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 1.47M | — | $124.86M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 1.47M | — | $124.86M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 1.47M | — | $124.86M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Morgan Stanley ✦ | 1.47M | — | $124.86M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Fidelity (FMR) ✦ | 1.43M | Baru | $121.46M | 0.0% | New | 1 | SEC ↗ |
| 9 | Fidelity (FMR) ✦ | 1.43M | Baru | $121.46M | 0.0% | New | 1 | SEC ↗ |
| 10 | Fidelity (FMR) ✦ | 1.43M | Baru | $121.46M | 0.0% | New | 1 | SEC ↗ |
| 11 | Millennium Management ✦ | 1.10M | -12.1% | $93.39M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 977.63K | Baru | $83.00M | 0.1% | New | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 681.78K | -45.6% | $57.88M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 681.78K | -45.6% | $57.88M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 479.87K | Baru | $40.74M | 0.0% | New | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 189.70K | Baru | $16.11M | 0.0% | New | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 189.70K | Baru | $16.11M | 0.0% | New | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 189.70K | Baru | $16.11M | 0.0% | New | 1 | SEC ↗ |
| 19 | Goldman Sachs Group ✦ | 135.63K | — | $11.51M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Geode Capital Management ✦ (pasif) | 29.85K | +77.5% | $2.53M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 27.54K | Baru | $2.34M | 0.0% | New | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Fidelity (FMR) | $121.46M | 0.0% |
| Fidelity (FMR) | $121.46M | 0.0% |
| Fidelity (FMR) | $121.46M | 0.0% |
| Adage Capital Partners | $83.00M | 0.1% |
| T. Rowe Price | $40.74M | 0.0% |
| Marshall Wace | $16.11M | 0.0% |
| Marshall Wace | $16.11M | 0.0% |
| Marshall Wace | $16.11M | 0.0% |
| D. E. Shaw & Co. | $2.34M | 0.0% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 250 pemegang, 49.39M saham, $5.28B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.